Valproate and neuroprotection

被引：29

作者：

Vajda, FJE

机构：

[1] Univ Melbourne, Raoul Wallenberg Ctr, Australian Ctr Clin Neuropharmacol, Fitzroy, Vic 3056, Australia

[2] St Vincents Hosp, Raoul Wallenberg Ctr, Australian Ctr Clin Neuropharmacol, Fitzroy, Vic 3065, Australia

来源：

JOURNAL OF CLINICAL NEUROSCIENCE | 2002年 / 9卷 / 05期

关键词：

D O I：

10.1054/jocn.2002.1133

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：508 / 514

页数：7

共 73 条

[1]

ANDREWS RJ, 1999, ANN NY ACAD SCI, V939, P114

[2]

[Anonymous], CLIN DIAGNOSIS MANAG

[3] VALPROIC ACID - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIAL IN INDICATIONS OTHER THAN EPILEPSY [J].

BALFOUR, JA ;

BRYSON, HM .

CNS DRUGS, 1994, 2 (02) :144-173

[4] The use of anticonvulsants in neurological conditions other than epilepsy - A review of the evidence from randomised controlled trials [J].

Beghi, E .

CNS DRUGS, 1999, 11 (01) :61-82

[5]

BLADIN PF, 2002, COMMUNICATION

[6] Hippocampal sclerosis following brief generalized seizures in adulthood [J].

Briellmann, RS ;

Newton, MR ;

Wellard, RM ;

Jackson, GD .

NEUROLOGY, 2001, 57 (02) :315-317

[7]

BRUNO V, 1995, FUNCT NEUROL, V10, P121

[8] VALPROATE IN THE TREATMENT OF PARTIAL EPILEPSIES [J].

CHADWICK, D .

EPILEPSIA, 1994, 35 :S96-S98

[9] Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus [J].

Chen, B ;

Wang, JF ;

Young, LT .

BIOLOGICAL PSYCHIATRY, 2000, 48 (07) :658-664

[10] The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS [J].

Chen, G ;

Zeng, WZ ;

Yuan, PX ;

Huang, LD ;

Jiang, YM ;

Zhao, ZH ;

Manji, HK .

JOURNAL OF NEUROCHEMISTRY, 1999, 72 (02) :879-882

← 1 2 3 4 5 6 7 8 →